Canada and Saskatchewan Announce Rare Disease Funding

Saskatchewan has entered a $40 million agreement with the federal government to enhance access to medications for residents diagnosed with rare diseases, including Poteligeo, Oxlumo, and Epkinly. Health Minister Jeremy Cockrill emphasized that the funding will support existing drug coverage and improve care for patients facing high treatment costs, which can reach up to $1.7 million for Oxlumo. Federal Health Minister Mark Holland highlighted the importance of this initiative, noting that approximately one in 12 Canadians will be diagnosed with a rare disease. The agreement also aims to develop better screening and diagnostics for these conditions in collaboration with other provinces. This partnership reflects a commitment from both levels of government to alleviate the financial burden on families dealing with rare diseases. Overall, the deal marks a significant step toward improving health outcomes for vulnerable patients in Saskatchewan.